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Abstract
There are scientific evidences that hypothermia provides a strong neuroprotec-
tive effect on the brain following traumatic insults. In this chapter, we describe the 
pathophysiology of severe head injury with emphasis on benefits of hypothermia. 
To support these hypothetical or theoretical benefits, we describe our previous 
study with very encouraging findings done on severe head injuries, treated with 
direct focal brain cooling, and monitored with intracranial pressure, cerebral perfu-
sion pressure, brain oxygenation, and brain temperature. This chapter ends with 
our current and still ongoing study in which one of its main objectives is to innovate 
a direct focal brain cooling machine. This chapter briefly explains the technical part 
of this cooling machine.
Keywords: hypothermia, trauma, brain oxygenation, brain temperature,  
intracranial pressure, severe head injury, focal brain cooling
1. Introduction
Severe traumatic brain injury (TBI) is one of the causes contributed to the major 
source of death and severe disability worldwide. In some countries, the increasing 
number of severe traumatic brain injury is alarming, bringing negative impact not 
just toward the individual itself, but also the society. Patients suffering from severe 
traumatic brain injury usually will end up with disability, as they most often are 
associated with extensive irreversible damages to the brain. This makes the manage-
ment of severe TBI to be challenging and very often associate with disappointing 
outcomes. Thus, severe TBI has become a common issue or interest that requires 
appropriate attention from various levels in order to reduce the damage impacts 
often associated with it. Many clinical trials and researches were conducted to 
improve our understanding and knowledge, with various treatment protocols being 
updated from time to time [1, 2].
During the trauma impact itself, there will be energy transfer to the brain tissue 
causing direct neuronal damages, causing irreversible damages to the neuronal 
structures, and affecting the neurophysiological function of the central nervous 
system. From the initial impact, primary injuries occur due to the direct impact and 
the damage that are usually irreversible. Secondary injuries will be subsequently 
triggered by hypoxic-ischemic event, inflammatory cytokines, and free radicals, 
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which are released by the injured neuronal cells. Secondary injuries play an impor-
tant role in determining posttraumatic recovery [3–5]. Secondary injuries will lead 
to breakdown of the cerebral blood brain barrier, leading to worsening cerebral 
edema and thus forming a vicious cycle toward further neuronal damages.
The management of severe TBI is aiming for restoration and maintenance of 
adequate brain perfusion to prevent hypoxia, surgical intervention for significant 
size of hematoma or edema, and prevention or prompt treatment of cerebral edema 
and raised intracranial pressure (ICP). However, clinical studies and analysis had 
proven that ICP and cerebral perfusion pressure (CPP) guided treatment alone, 
does not necessarily prevent hypoxic-ischemic damage to the brain [6]. Despite 
knowing that ICP remains the most important determinant factors of mortality out-
come in severe head injury patients, brain hypoxia (defined as PbtiO2 < 10 mmHg 
and for more than 15 minutes) is actually more important in determining the 
morbidity and patient functional outcome [7].
Many new strategies and alternative protocols are introduced to improve the 
management and outcome of severe TBI patients. Throughout the years, the defini-
tion of adequate cerebral resuscitation including the targeted ICP and CPP values 
are often debatable. Other treatment strategy such as PbtiO2, plus ICP and CPP 
guided therapy showed promising result, with reduced hypoxic-ischemic damages 
to the brain and better patient functional outcome recovery.
Controlled systemic hypothermia treatment in managing severe head injury 
patient, is associated with neuroprotective effect to the injured brain tissue. 
Hypothermia significantly reduce metabolic rate and energy expenditure, attenu-
ate excitatory amino acids and the synthesis of free radicals, suppresses excessive 
ischemia-induced and posttraumatic inflammatory reactions, and prevent blood-
brain barrier disruption and brain edema. Furthermore, hyperthermia in head 
injury increases postischemic injury and is a significant predictor of poor outcome. 
Induced and controlled systemic hypothermia is used in patient with stroke, 
perinatal asphyxia, hypoxic encephalopathy following cardiovascular arrest with 
improved recovery, and functional outcome documented [8–11]. However, the pit-
fall of the treatment is that it is associated with alteration of the body core tempera-
ture and hence induced alteration in the systemic function and affecting the whole 
body hemostasis. Few possible adverse systemic complications that are associated 
with induced systemic hypothermia treatment include increase risk of infection 
and sepsis, pneumonia, poor wound healing and breakdown, cardiac arrhythmias, 
coagulopathy and electrolytes imbalances such as hypoglycemia and hypokalemia 
[12–18]. These systemic complications may outweigh the beneficial effect of the 
hypothermia treatment. Thus, treatment with induced and controlled systemic 
cooling therapy in head injury patient has become an interesting but controversial 
subject. Given so much controversy in inducing hypothermia for the injured brain, 
we sought to design a prospective, randomized pilot study to assess efficacy of new 
method in brain cooling called “direct regional or focal brain hypothermia.” In 
this chapter, we present our experience with direct focal or regional brain cooling, 
obtained via direct irrigation of cold fluid onto the surface of severely injured brain 
of trauma patients who required decompressive craniectomy with Glasgow Coma 
Score (GCS) of 6–7, and the chapter ends with our current and still ongoing study in 
which, one of its main objectives is to innovate a direct focal brain cooling machine.
2. Role of hypothermia in head injury patient
There have been multiple mechanisms suggesting benefit of hypothermia in head 
injury patient. However, there is likely that no single factor can be used to explain 
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the neuroprotective effect of hypothermia. Understanding the combination of the 
factors may help us understand better the effect of hypothermia [3]. The proposed 
mechanisms are summarized below [12, 19, 20] and depicted as in Figure 1.
a. Hypothermia can inhibit the activation of caspase enzymes.
b. It prevents or mitigates mitochondrial dysfunction.
c. It decreases the metabolism as well as decreases the overload of excitatory neu-
rotransmitters such as glutamate and free oxygen radicals.
d. It modifies the cellular disorders of intracellular ion concentrations.
e. It suppresses the inflammatory and immunological responses and epileptic 
activity.
f. It reduces the disruption in blood brain barrier (BBB), vascular permeability, 
and edema.
g. It improves the microcirculatory circuits and intra- and extracellular acidosis.
h. It corrects the hyperthermia after brain injury and influences the local secretion 
of various vasoactive mediators secreted by the endothelium.
i. It enhances expression of immediate early genes and cold shock proteins.
j. Hypothermia may also influence neurogenesis, gliogenesis, and angiogenesis.
Figure 1. 
Effect of hypothermia on pathophysiology of brain injury. Therapeutic hypothermia works by reducing the 
detrimental consequence of secondary brain injury (black stars).
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3.  Current evidences on the usage of direct brain cooling in treating 
severe head injury: animal studies
There are previously multiple papers that suggested targeted brain cooling as a 
reasonable treatment option to patient with severe traumatic brain injury [21–33]. 
Targeted brain cooling is a good alternative to systemic hypothermia, as systemic 
hypothermia has serious side effects such as circulatory constrain, increased risk of 
infection, electrolyte imbalance, and coagulopathy [15–18].
Jacek et al. [33] suggested in their animal study that selective brain hypothermia, 
which is applied via a cranial window after decompressive craniectomy seems to 
be reducing posttraumatic structural and functional damage. However, the study 
is actually limited by small rodent model and also short observational period. It is 
suggested that thermodynamic of brain of human rodent may differ as the size is 
significantly different. It may affect the penetration of the cooling effect in human 
brain, hence limiting the cooling effect to the superficial areas only.
4.  Current evidences on the usage of direct brain cooling in treating 
severe head injury: our clinical study
Here, we describe our pilot study on direct focal hypothermia therapy in treat-
ing severe head injury with positive and very encouraging results that enable us 
to proceed with another innovative study to create a direct hypothermia machine, 
which will be used in our ongoing study.
4.1 Methodology
This is a randomized controlled trial study, which is designed to answer the 
research questions regarding the effect of direct focal brain cooling treatment 
in severe head injury patients. The study has been approved by the research and 
ethics committee and is sponsored by the Research University Grant. Patients were 
randomized into two treatment groups of A and B. Group B is the control group.
Group A (treatment group) consists of patients, who have therapy with direct focal 
brain cooling. All patients have intracranial pressure monitoring, Licox (focal brain oxy-
genation and temperature) probes inserted, and blood for immunological parameters. 
The immunological blood parameters are however taken only prior and after local cool-
ing therapy to the brain. The overall monitoring and therapy period was for 48 hours.
The neurosurgical operations are standard operations, decompressive crani-
ectomy covering frontal, parietal and temporal lobes; intracranial pressure probe 
insertion into the ventricle or parenchyma of the brain, and Licox probe into 
abnormal brain areas. The monitorings and therapies given after the surgery are the 
standard therapy for severe head injury patient (Figure 2). They include sedation 
with or without muscle paralysis agents, ventilator support, hypertonic saline or 
mannitol, draining of cerebrospinal fluid (CSF) for the persistent raise in intracra-
nial pressure (ICP) of more than 20 mmHg and thiopentone coma therapy as a final 
step to treat persistently raised ICP.
Direct focal brain cooling method done through persistently irrigating the brain 
with cold Hartmann’s solution in which the temperature of the infused fluid is 
divided into two subgroups as follow:
1. Deep cooling: temperature of 20–29°C.
2. Mild cooling: temperature of 30–36°C.
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The Hartmann’s solution was infused via Neurojaf external ventricular drain-
age (EVD) catheter, which was inserted superior to the dura flap and at the inner 
surface of the dura, acting like rains flushing through the surface of the swollen 
brain (multiple extra holes are made). The catheter is in contact with the surface of 
the brain. The infusion rate is 70 mls/hr. Due to the position of the head, the second 
draining tube will be inserted at the lower part of the craniectomy flap outside the 
dura (which is closed loosely) to drain the excess fluid with low suction pressure. 
The temperature of the infused Hartmann’s solution is checked via the three-way 
connector draining the fluid out to the collection port for temperature assessment. 
If temperature reading is under or above the intended value, new solution with 
correct intended temperature will replace the previous one.
All patients will have CT scan done if the ICP shows persistently raised values 
despite of standard therapies given. This is important to exclude any new surgical 
lesion and to exclude the retention of infused solution as a cause of raised ICP. If 
Figure 2. 
Direct brain cooling monitoring and therapy. (A) intraoperative bifrontal decompressive craniectomy with 
insertion of Licox and ICP probes; (B) inset image: Post-op CT scan; (C) neurointensive care management and 
monitorings with Licox, cardiac parameters, ICP, bispectral index (BIS) and electroencephalography (EEG).
No cooling Mild 
cooling
Deep 
cooling
Total
Total patients 13 10 9 32
Variables No cooling Mild cooling Deep 
cooling
P value
Age (mean in years) [95% CI] 45.5 [35.0–56.1] 28.9 
[17.3–40.5]
26.7 
[11.9–41.4]
0.02
Gender (number):
1. Male 10 8 9
2. Female 3 2 0 0.40
GCS (median) 6 7 7 0.38
Injury Severity Score (mean) [95% CI] 27.8 [21.2–34.5] 24.0 
[18.5–29.5]
28.7 
[21.3–36.0]
0.56
Marshall Score (median) 4 4 3 0.33
Patients with disseminated 
intravascular coagulopathy (DIVC)
3 2 4 0.44
Table 1. 
Basic parameters comparison among three studied groups.
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the ICPs show normal values, the CT scan of the brain is done after 48 hours of 
therapy prior to removal of the EVD tube to document the location of the EVD tip. 
The measured outcomes are: (a) trend and values for monitored parameters (ICPs, 
CPPs, brain temperature and focal brain oxygenation), (b) Glasgow Outcome Score 
(GOS – good and poor GOS), and (c) immunological parameters.
4.2 Results
4.2.1 Social demographic data of patients included in the study
There were 32 patients recruited in this study with 27 male patients and 5 female 
patients. The median age of patients recruited were 45.5 in no cooling group, 
whereas 28.9 and 26.7, respectively, for mild cooling and deep cooling groups. 
Median GCS for the patients recruited were 6–7. The highest injury severity score 
recruited was 36, whereas the lowest was 18.5. The median Marshall score for 
patient recruited were 3–4. Patients with disseminated intravascular coagulopathy 
for no cooling, mild cooling, and deep cooling were 3, 2, and 4 patients, respec-
tively. The demographic data is shown in Table 1.
4.2.2  Effects of direct focal brain cooling on median ICP, CPP, brain oxygenation, 
and temperature
The trend of the ICPs, CPPs, brain temperature, and focal brain oxygenation for 
all studied groups are shown in Figure 3A–D. During 48 hours of observation and 
monitoring, there is no significant statistical difference in overall 4 hourly mean 
ICPs, CPPs, and brain temperature amongst the no cooling, mild cooling, and deep 
cooling groups; but there is significant statistical difference in overall 4 hourly 
mean focal brain oxygenation according to repeated measure ANOVA (between 
groups analysis based on time) (depicted in Tables 2 and 3).
Figure 3. 
(A) Trend of ICPs in the first 48 hours after the treatment. (B) Trend of brain temperature observation for the 
first 48 hours after treatment. (C) Trend of CPPs in the first 48 hours after the treatment. (D) Trend of brain 
oxygen observation for the first 48 hours after treatment.
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Table 2 shows day 1 of monitoring and treatment, mean brain oxygenation of 
mild cooling group has mostly fallen outside the 95% CI (confidence interval) of 
deep cooling group. Therefore, there is significant difference in mean brain oxygen 
between mild cooling and deep cooling; with mild cooling having significantly 
higher mean brain oxygen values. On day 2 of monitoring and treatment, mean 
brain oxygenation of no cooling group has mostly also fallen outside the 95% CI of 
mild cooling group. Therefore, there is significant difference in mean brain oxygen 
between no cooling and mild cooling. Likewise to day one findings, there is also 
a significant difference on day 2 in mean brain oxygen between mild cooling and 
deep cooling. Interestingly, in all group comparisons, mild brain cooling group has 
significantly higher mean brain oxygenation values as compared to either deep or 
no cooling group (depicted in Table 3).
4.2.3 Effect of regional brain cooling on GOS at discharge and at 6 months
There is no significant difference in GOS at time of discharge for both studied 
groups (no cooling vs. cooling groups). However, there is significant difference on 
good GOS in cooling group compared to no cooling group at 6 months follow-up 
(as shown in Table 4 with p < 0.007). On stratifying the cooling group further 
into deep and mild cooling, it shows that there is significant difference in term of 
GOS score at 6 months with significant better outcomes noted in mild cooling as 
compared to no cooling group with p < 0.013. The deep cooling group at 6 months 
outcome, failed to have significant difference value when compared with either 
no or mild cooling groups. For this reason, direct and mild brain hypothermia 
Time (Day 1) Treatment group Mean brain oxygen 95% confidence interval (CI)
0 hour No cooling 18.94 8.29–29.60
Mild cooling 28.27 15.54–41.01
Deep cooling 13.82 1.91–25.73
4 hour No cooling 20.78 11.72–29.83
Mild cooling 31.17 20.35–41.99
Deep cooling 14.43 4.31–24.55
8 hour No cooling 21.55 12.40–30.70
Mild cooling 31.39 20.45–42.32
Deep cooling 15.33 5.10–25.56
12 hour No cooling 23.27 15.31–31.22
Mild cooling 31.14 21.64–40.65
Deep cooling 16.89 8.00–25.78
16 hours No cooling 25.96 16.30–35.62
Mild cooling 36.93 25.38–48.47
Deep cooling 20.36 9.56–31.16
20 hours No cooling 26.64 16.22–37.05
Mild cooling 39.11 26.67–51.56
Deep cooling 22.51 10.86–34.15
Statistical analysis: Repeated Measure ANOVA (between groups analysis based on time).
Table 2. 
Comparison of mean brain oxygen between three treatment groups based on 4 hourly observations (day 1).
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with coolant temperature of 30–36°C might truly be beneficial to the severely 
head injured patients. Having said that, obviously future studies are still needed to 
ascertain this finding with higher number of more homogenous recruited patients.
4.2.4 Effects of regional brain cooling on immunological parameters
There is no significant difference on immunological parameters upon comparing 
prior and after cooling therapy. Nonetheless, the postcooling immunological param-
eters seem to have lower values than the precooling ones (depicted in Table 5).
4.3 Discussion
This was a randomized controlled pilot study involving 32 patients, who were 
admitted to our hospital with severe head injury with GCS of 6 or 7. The aim was to 
study the effect of direct focal brain cooling therapy in severe head injury patients.
4.3.1 Effect of direct focal brain cooling on brain oxygen level
All the treatment groups were able to reach the desired mean brain oxygen level 
within the treatment period. Notwithstanding, the mean brain oxygen of mild cool-
ing group was significantly higher as compared to the no- and deep cooling groups. 
It remained significantly higher throughout the treatment periods (24–48 hours) 
with the level of >50 mmHg. The mean brain oxygen of deep cooling group was the 
Time (Day 2) Treatment group Mean brain oxygen 95% confidence interval (CI)
0 hour No cooling 28.00 16.98–39.03
Mild cooling 48.73 31.89–65.58
Deep cooling 28.91 14.32–43.49
4 hours No cooling 29.20 16.98–41.43
Mild cooling 50.17 31.50–68.84
Deep cooling 28.13 11.96–44.30
8 hours No cooling 28.96 17.57–40.35
Mild cooling 52.27 34.87–69.66
Deep cooling 34.39 19.33–49.46
12 hours No cooling 27.46 18.63–36.30
Mild cooling 52.00 38.51–65.49
Deep cooling 33.69 22.01–45.38
16 hours No cooling 30.63 21.34–39.92
Mild cooling 51.60 37.41–65.79
Deep cooling 35.17 22.88–47.45
20 hours No cooling 30.05 20.01–40.08
Mild cooling 50.57 35.24–65.90
Deep cooling 36.12 22.84–49.39
Statistical analysis: Repeated Measure ANOVA (between groups analysis based on time).
Table 3. 
Comparison of brain oxygen between three treatment groups based on 4 hourly observations (day 2).
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lowest but still did not reach the critical ischemic state (10–15 mmHg). Despite of 
having the lowest brain oxygen level on day 1, the improvement in brain oxygen 
level in deep cooling group was accelerated and reached the desirable range after 
16 hours of treatment (with mean brain oxygen of >20 mmHg).
Patients with severe head injury were at higher risk of developing cerebral 
ischemia particularly in the first 48 hours. Cerebral ischemia was defined by brain 
oxygen of <10 mmHg for more than 2 hours [34]. Low mean brain oxygen pressure 
often associated with poorer clinical outcome, while patients with good GOS often 
had good or normalized reading within 2 hours after the injury. Brain oxygen level is 
a good indicator of functional outcome in addition to ICP and CPP. Targeted therapy 
of ICP < 15 mmHg, CPP > 75 mmHg, and brain oxygen >25 mmHg often associated 
with good clinical outcomes. The clinical trials comparing the ICP-CPP guided 
therapy to ICP-CPP-brain oxygen guided therapy showed significant better func-
tional outcome at 6 months and lower mortality rate in the latter group [34, 35].  
This showed that ICP-CPP-brain oxygen guided therapy is beneficial in treating 
severe head injury patients as it can improve the patient outcomes.
Outcomes (GOS) No cooling  
[13 patients]
Cooling group [19 patients] p 
value
Poor GOS (GOS 1–3)
Good GOS (GOS 4–5)
Comparing 2 groups
GOS at discharge:
a. Poor GOS 12 (92.3%) 15 (78.9%) 0.307
b. Good GOS 1 (7.7%) 4 (21.1%)
GOS at 6 months:
a. Poor GOS 11 (84.6%) 7 (36.8%) 0.007*
b. Good GOS 2 (15.4%) 12 (63.2%)
Comparing 3 groups No cooling [n (%)] Mild cooling  
[n (%)]
Deep cooling 
 [n (%)]
GOS at 6 months:
a. Poor GOS 11(84.6%) 3 (30%) 4 (44.4%) 0.023*
b. Good GOS 2 (15.4%) 7 (70%) 5 (55.6%)
GOS at 6 months:
a. Poor GOS 11 (84.6%) 3 (30%) 0.013*
b. Good GOS 2 (15.4%) 7 (70%)
GOS at 6 months:
a. Poor GOS 11 (84.6%) 4 (44.4%) 0.074
b. Good GOS 2 (15.4%) 5 (55.6%)
GOS at 6 months:
a. Poor GOS 3 (30%) 4 (44.4%) 0.650
b. Good GOS 7 (70%) 5 (55.6%)
*Statistically significant. Statistical analysis: Pearson Chi-squared test.
Table 4. 
Effect of regional brain cooling on GOS at discharge and at 6 months; and effect of regional brain cooling on 
GOS only at 6 months, after stratifying the cooling group further into mild and deep cooling.
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4.3.2 Effect of direct focal brain cooling on ICP and CPP
The mean ICP did not show any significant difference amongst the studied groups 
as shown in the results above. There was also no evidence of refractory intracranial 
hypertension throughout the treatment period in all three groups, indicating that the 
focal cooling therapy used in this study was safe and not associated with risk of intra-
cranial hypertension. The results seemed to contradict the effect of hypothermia, 
which supposed to have better control on ICPs, and hence, leading to better CPPs 
and mean brain oxygenation. Previous clinical study on the effect of mild systemic 
hypothermia to the head injury patients clearly had established a significant reduction 
in ICPs following cooling therapy [36]. The mechanisms of reduction in ICP values 
were postulated to be due to reduced cerebral edema, following an improvement of:
1. the blood brain barrier [37],
2. vascular permeability of microvascular endothelial cells [38],
3. extravasation of hemoglobin [39],
4. membrane disintegration processes,
5. cytotoxic edema via decreased inflammatory reactions and free radical forma-
tion within the brain, and
6. ion homeostasis including calcium [40].
Reduction in ICP and improvement in CPP did not happen in our pilot study, 
perhaps, because decompressive craniectomy had been completed prior to direct 
hypothermia therapy. Hence, intracranial pressure and perfusion pressure effects 
might not be shown-up in this particular study. Nevertheless, future related study 
should be carried out with more homogenous patients to confirm this finding.
Precooling 
(mean ± SD)
Postcooling 
(mean ± SD)
Wilcoxon signed 
Ranked test (p value)
T-cell markers (cells/mm3)
CD 3 776.8 (407.5) 756.3 (339.9) 0.86
CD 4 443.1 (268.5) 429.7 (210.0) 0.64
CD 8 328.1 (183.6) 301.7 (135.7) 0.96
CD 19 284.4 (168.6) 261.5 (126.6) 0.62
CD 16 and 56 172.4 (113.8) 112.7 (80.8) 0.05
Pro-inflammatory cytokines (pg/ml)
Interleukin-1 (IL-1) 45.34 (130.7) 5.7 (13.0) 0.33
Interleukin-6 (IL-6) 278.5 (221.1) 190.0 (208.4) 0.44
Tumor necrosis factor (TNF) 34.5 (37.6) 18.1 (14.2) 0.41
Other immunological parameters
Total WBC 13.6 (5.0) 12.8 (4.0) 0.16
Table 5. 
Effect of regional brain cooling (both mild and deep cooling groups combined together) on immunological 
parameters.
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4.3.3 Effect of direct focal brain cooling on brain temperature
There was no significant difference in brain temperature in all treatment groups 
as shown above in trend-results, thus showing that focal cooling did not seem to be 
effective in reducing focal brain temperature. This study was initially designed to 
reduce brain temperature; the mechanism of temperature reduction was thought to 
be achieved through two ways, which were direct cooling effect over the brain sur-
face (via continuous irrigation of the cold Hartmann fluid) as well as through the 
indirect cooling effect (to the deeper part of the brain) via circulation and pulsation 
around the brain and cisterns. However, it seemed that the targeted effect was not 
achieved. This can be due to many factors including poor CSF circulation, and 
hence affecting the thermoregulation of the brain. It is worth mentioning that there 
is limitation of Licox probe as well. This device was specifically designed to detect 
the changes occurred around the area where it was inserted. Hence, it was unable to 
reflect accurately the whole brain temperature changes following head injury [41].
It was well documented in the literature that an injured brain might have 
significantly higher temperature compared to the core body temperature; rang-
ing from 0.1°C to more than 2°C. The difference in the temperature gradient may 
be more significant in an injured brain as a result of destructive hyperactivity 
of the injured cells [42]. Numerous clinical studies have found that higher brain 
temperature is associated with adverse outcome and negative correlation with the 
prognosis of head injury patients. Hyperthermia increases the risk of ischemic area 
to become necrotic or apoptotic. In animal model, transient increase in core body 
temperature to 39–40°C led to 2.6-fold increase in the extent of neuronal injury in 
the hippocampus [43]. Since hyperthermia was an important independent factor of 
adverse neurological outcome and increase mortality in brain injury [44], accurate 
brain temperature reading was rather essential. For future reference, focal brain 
temperature reading with Licox may be combined with adjunct devices such as CT 
thermography as it can accurately measure the focal and whole brain temperature 
for better comparison during treatment.
4.3.4 Effect of direct focal brain cooling on the Glasgow Outcome Score (GOS)
Patients GOS was the most important factor to determine the outcome of the 
focal brain cooling treatment in this study. This classification system was specifi-
cally designed to help clinicians to determine the patients response following the 
treatment by assessing their functional status at discharge and at 6 months after the 
injury; score 1 reflects mortality, score 2 and 3 reflect significant morbidity, while 
score 4 and 5 reflect ability to function normally or near normal. The outcomes were 
promising as significant difference was noted, whereby the proportion of patients 
who received direct focal brain cooling treatment showed better GOS score of 4 and 
5 at 6 months follow-up when compared to the no cooling group. However, no signif-
icant difference was established in GOS at day of discharge. The outcome of patient 
in severe head injury is actually multifactorial and could not just be attributed to a 
single factor. The age, other associated injuries, and hemodynamic instability will all 
contribute to the outcomes of the patients. The obvious contributing factor in our 
study is the increment in focal brain oxygenation during cooling therapy and it is 
markedly obvious in mild cooling group who received cold-fluid of 30–36°C.
4.3.5 Effect of direct focal brain cooling on immune responses
In this study, the T-cell markers, pro-inflammatory cytokines, and total 
white cell count show reduction in values after cooling therapy; nonetheless, no 
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significant statistical difference noted in each studied immune parameters. This 
may be due to our small sample size; therefore, future related study should con-
sider to recruit more patients with better homogenous participants’ population. 
Besides this drawback, another shortcoming is no level taken from non-cooling 
group for comparison, thus the true effect of regional brain cooling on immuno-
logical biomarkers cannot be truly ascertained. This initial result, however, might 
indicate that focal brain cooling treatment has little adverse effect onto immune 
responses, which often associated with induced systemic cooling. Following head 
injury, acute immunological responses to the trauma begin around 1 hour after 
the injury until several days. Pro inflammatory mediators such as tumor necrosis 
factors-alpha (TNF-α) and IL-1 are released from injured tissues and stimulate 
the migration of the leukocytes across the BBB. These lead to accumulation of the 
inflammatory cells in the injured brain within hours. Activation of the comple-
ment systems following head injury will stimulate the neutrophil and in later 
stages, also monocytes and macrophages. These initial stages are basically causing 
granulocytosis (up to 90%), increasing immunoglobulins (Ig)-E, slight increase 
or normal level of monocytes, B-lymphocytes as well as Ig-A, -G and -M. On the 
other hand, there is suppression of the other lymphocytes subsets particularly the 
CD3, CD4 and CD8 counts [45]. Some of these changes were found to be benefi-
cial and associated with neuroprotective effects while some other inflammatory 
mediators were neurotoxic [46]. The CD3, CD4, and CD8 counts are normally sup-
pressed after few hours following severe head injury. This level will remain low for 
the next 24–48 hours and generally normalized after 3 days. The CD8 count tends 
to normalize faster than the CD3 and CD4. Increased risk of infection had been 
attributed to the suppression of these cellular immunities. Besides these mecha-
nisms in causing alterations in immune parameters, other possibilities should also 
be considered. Those possibilities include:
1. blood product transfusion pre-, intra-, or postoperatively,
2. possibility of neuroendocrine changes,
3. the duration of the surgery,
4. the incidence of pre- and intraoperative hypothermia, which were not docu-
mented, and
5. the severity of trauma with consideration of the extend of tissues damaged [47].
5.  Current innovation in direct focal brain cooling: D-Brain Cooling 
Machine™
The internal cooling methods use central venous catheters to either infuse cold 
saline or directly to reduce the blood temperature by convection. By advancement 
in microelectronic industry, instrumentation system can be integrated on chip level 
that can miniaturize the system to micro dimension. One of the advancements is 
miniaturization of micro-controller that can be easier to interface with sensing 
instrumentation system. Thus in this project, simple and intelligent localized brain 
cooling instrument by using Programmable System on Chip (PSoC) is proposed. 
Advantages of this system are simple, can localize coolant area in brain and System 
on chip (SoC) based automation system. This project involves designing temperature 
chamber to place the sterile fluid that is connected with antibiotic piping directly to 
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the brain location. This chamber will be integrated with temperature controller, then, 
processed by PSoC microcontroller, as shown in Figure 4A and B. Subsequently, 
sensing and micro-controller will be interfaced to the system for temperature display. 
This direct brain cooling machine is known as D-Brain Cooling Machine™.
6. Conclusions
This chapter highlights the fascinating result of our pilot study on direct focal 
brain cooling therapy in severe head injury patients. The significant clinical out-
come results seem in mild cooling group is thought to be due to an elevation in 
oxygenation level of injured and decompressed brain tissues. Thus, direct brain 
cooling therapy seems as a promising treatment in severe head injuries, and should 
be considered by neurosurgeon and neurointensivist as an adjunctive method to 
decompressive craniectomy. Therefore, combination of both therapies may help 
many diffused and severely injured brains secondary to neurotrauma in gain-
ing better clinical outcomes. Base on this initial and encouraging results, there is 
ongoing study by our group on direct focal brain cooling therapy in severely head 
injured patients by using newly invented cooling machine named D-Brain cooling 
machine™ therapy.
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